Page 21 - Precision Vaccines Program News Today

A deadly new virus, which causes respiratory illness, is spreading around the world. Stay up to date with the latest information on the coronavirus.

The end of the pandemic is coming. Heres what it will take. Erika Edwards and Akshay Syal © Provided by NBC News Perhaps the most important thing to know about 2021 is that it will be different than 2020. Unfortunately, the pandemic will not magically end when the clock strikes midnight on New Years Eve —one year since a mysterious pneumonia spreading in Wuhan, China, was first publicly disclosed. More cases will be diagnosed in the new year, and more people will die from th...

FDA committee votes to recommend emergency authorization of Pfizer virus vaccine UPDATE: A U.S. government advisory panel on Thursday decided to endorse large-scale use of Pfizer’s Covid-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans. The advisory group, in 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older. The meeting of outside advisers to the Food and Drug Administration repre...

Updated on December 10, 2020 at 7:45 pm NBC Universal, Inc. Three Massachusetts doctors are on the U.S. Food and Drug Administration’s vaccine advisory panel that met Thursday to discuss whether or not the agency should approve Pfizers COVID-19 vaccine for emergency use. Drs. Cody Meissner from Tufts, Eric Rubin from Harvard T.H. Chan School of Public Health, and Ofer Levy from Boston Childrens Hospital and the rest of the FDA advisory committee participated in a virtual meeting Thursday. The...

Mass. Doctors Play Key Role in Pfizer Vaccine Hearing © Provided by New England Cable News A member of staff poses with a phial of Pfizer-BioNTech Covid-19 vaccine at a vaccination health centre on the first day of the largest immunisation programme in the UK’s history on December 8, 2020 in Cardiff, United Kingdom. Three Massachusetts doctors are on the U.S. Food and Drug Administration’s vaccine advisory panel that met Thursday to discuss whether or not the agency should approve Pfizers...